1
TÍTULO: Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial
AUTORES: Stefano Barco; Irene Schmidtmann; Walter Ageno; Rupert M Bauersachs; Cecilia Becattini; Enrico Bernardi; Jan Beyer Westendorf; Luca Bonacchini; Johannes Brachmann; Michael Christ; Michael Czihal; Daniel Duerschmied; Klaus Empen; Christine Espinola Klein; Joachim H Ficker; Candida Fonseca; Sabine Genth Zotz; David Jimenez; Veli Pekka Harjola; Matthias Held; Lorenzo Iogna Prat; Tobias J Lange; Athanasios Manolis; Andreas Meyer; Pirjo Mustonen; Ursula Rauch Kroehnert; Pedro Ruiz Artacho; Sebastian Schellong; Martin Schwaiblmair; Raoul Stahrenberg; Peter E Westerweel; Philipp S Wild; Stavros V Konstantinides; Mareike Lankeit; ...Mais
PUBLICAÇÃO: 2020, FONTE: EUROPEAN HEART JOURNAL, VOLUME: 41, NÚMERO: 4
INDEXADO EM: Scopus WOS
2
TÍTULO: Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
AUTORES: Giancarlo Agnelli; Cecilia Becattini; Guy Meyer; Andres Munoz; Menno V Huisman; Jean M Connors; Alexander Cohen; Rupert Bauersachs; Benjamin Brenner; Adam Torbicki; Maria R Sueiro; Catherine Lambert; Gualberto Gussoni; Mauro Campanini; Andrea Fontanella; Giorgio Vescovo; Melina Verso;
PUBLICAÇÃO: 2020, FONTE: NEW ENGLAND JOURNAL OF MEDICINE, VOLUME: 382, NÚMERO: 17
INDEXADO EM: WOS
3
TÍTULO: Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study
AUTORES: Giancarlo Agnelli; Cecilia Becattini; Rupert Bauersachs; Benjamin Brenner; Mauro Campanini; Alexander Cohen; Jean Marie Connors; Andrea Fontanella; Gualberto Gussoni; Menno V Huisman; Catherine Lambert; Guy Meyer; Andres Munoz; Joaquim Abreu de Sousa; Adam Torbicki; Melina Verso; Giorgio Vescovo;
PUBLICAÇÃO: 2018, FONTE: THROMBOSIS AND HAEMOSTASIS, VOLUME: 118, NÚMERO: 9
INDEXADO EM: Scopus WOS
4
TÍTULO: Home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban Rationale and design of the HoT-PE Trial
AUTORES: Stefano Barco; Mareike Lankeit; Harald Binder; Sebastian Schellong; Michael Christ; Jan Beyer Westendorf; Daniel Duerschmied; Rupert Bauersachs; Klaus Empen; Matthias Held; Martin Schwaiblmair; Candida Fonseca; David Jimenez; Cecilia Becattini; Kurt Quitzau; Stavros Konstantinides;
PUBLICAÇÃO: 2016, FONTE: THROMBOSIS AND HAEMOSTASIS, VOLUME: 116, NÚMERO: 1
INDEXADO EM: Scopus WOS
5
TÍTULO: Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer. A Randomized Clinical Trial
AUTORES: Agnes Y Y Lee; Pieter W Kamphuisen; Guy Meyer; Rupert Bauersachs; Mette S Janas; Mikala F Jarner; Alok A Khorana;
PUBLICAÇÃO: 2015, FONTE: JAMA, VOLUME: 314, NÚMERO: 7
INDEXADO EM: CrossRef
6
TÍTULO: International Clinical Practice Guidelines for the Treatment and Prophylaxis of Thrombosis Associated with Central Venous Catheters in Patients with Cancer
AUTORES: Debourdeau Philippe; Farge Dominique; Beckers Marielle; Caroline Baglin; Rupert Bauersachs; Benjamin Brenner; Dialina Brillhante; Anna Falanga; Grigoris T Gerotziafas; Nissim Haim; Ajay Kakkar; Alok A Khorana; Ramon Lecumberri; Mario Mandala; Michel Marty; Manuel Monreal; Shaker S Mousa; Simon Noble; Ingrid Pabinger; Paolo Prandoni; Martin Prins; Mohammed H Qari; Michael B Streiff; Konstantin Syrigos; Harry Roger Buller; Henri Bounameaux; ...Mais
PUBLICAÇÃO: 2012, FONTE: 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) in BLOOD, VOLUME: 120, NÚMERO: 21
INDEXADO EM: WOS